- What can we expect from Raloxifene in the treatment of postmenopausal osteoporosis: gynaecological point of view2002 | Publication without faculty affiliation
- Monitoring of bone changes in women treated with raloxifene2003 | First Faculty of Medicine
- The effect of raloxifen treatment in postmenopausal women with CKD2008 | First Faculty of Medicine
- Position of raloxifene in prevention and treatment of osteoporosis2000 | First Faculty of Medicine
- Selected questions and answers from the Drug Information Centre: What is the mechanism of action and clinical experience with raloxifene?1998 | Faculty of Pharmacy in Hradec Králové
- Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality2020 | First Faculty of Medicine, Faculty of Science
- Raloxifen - výskyt vedlejších účinků u pacientek užívajících raloxifen a jejich následná verifikace2002 | Faculty of Medicine in Pilsen
- Role of cortical bone in resistance to fracture2017 | Faculty of Medicine in Pilsen
- Raloxifen prevents bone loss in castrated male mice2007 | First Faculty of Medicine
- The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis2006 | First Faculty of Medicine
- The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis2006 | Faculty of Physical Education and Sport
- Effect of raloxifene on bone mineral density and markers of bone remodeling following alendronate therapyPublication without faculty affiliation
- Effect of raloxifene on bone mineral density and markers of bone remodeling following aledronate therapy-two year follow-upPublication without faculty affiliation
- Biochemical markers of type 1 collagen synthesis and degradation in monitoring osteoporosis treatment with raloxifene or alendronatePublication without faculty affiliation
- Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial2003 | First Faculty of Medicine
- Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial2003 | Faculty of Physical Education and Sport
- The effect of raloxifene following discontinuation of long-term alendronate treatment of postmenopausal osteoporosisPublication without faculty affiliation
- Stratification of treatment of postmenopausal osteoporosis2004 | First Faculty of Medicine
- Raloxifene increases intestinal calcium absorption in elderly postmenopausal women with osteoporosisPublication without faculty affiliation
- Continued breast cancer risk reduction in postmenopausal women with raloxifene: 4-years results from the MORE trial2001 | First Faculty of Medicine
- The effect on bone turnover of monofluorophosphate (MFP) combined with raloxifene (RLX) as compared to MFP alone in postmenopausal women with low bone massPublication without faculty affiliation
- Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone2009 | First Faculty of Medicine
- Guidelines for diagnostics and therapy of postmenopausal osteoporosis. First part2007 | Publication without faculty affiliation
- Guidelines for diagnostics and therapy of postmenopausal osteoporosis. First part2007 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Guidelines for diagnostics and therapy of postmenopausal osteoporosis. First part2007 | First Faculty of Medicine
- BMD and fracture effects of monofluorophosphate (MFP) combined with raloxifene (RLX) as Compared to MFP alone in postmenopausal women with low bone massPublication without faculty affiliation
- Calcitonin in practice of out patients departments for climacteric disorders2004 | First Faculty of Medicine
- Osteology2009 | First Faculty of Medicine
- Selektivní modulátor estrogenových receptorů DT56a2015 | Third Faculty of Medicine
- Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis2003 | First Faculty of Medicine